Cargando…
Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial
BACKGROUND: Overdoses due to non-medical use of prescription opioids and other opiates have become the leading cause of accidental deaths in the USA. Buprenorphine and extended-release naltrexone are key evidence-based pharmacotherapies available to addiction treatment providers to address opioid us...
Autores principales: | Molfenter, Todd, Knudsen, Hannah K., Brown, Randy, Jacobson, Nora, Horst, Julie, Van Etten, Mark, Kim, Jee-Seon, Haram, Eric, Collier, Elizabeth, Starr, Sanford, Toy, Alexander, Madden, Lynn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688699/ https://www.ncbi.nlm.nih.gov/pubmed/29141653 http://dx.doi.org/10.1186/s13012-017-0665-x |
Ejemplares similares
-
Prescribers’ satisfaction with delivering medications for opioid use disorder
por: Knudsen, Hannah K., et al.
Publicado: (2021) -
Physicians’ satisfaction with providing buprenorphine treatment
por: Knudsen, Hannah K., et al.
Publicado: (2019) -
Payer Policy Behavior Towards Opioid Pharmacotherapy Treatment in Ohio
por: Molfenter, Todd, et al.
Publicado: (2018) -
Opening the “black box” of organizational coaching for implementation
por: Fleddermann, Kathryn, et al.
Publicado: (2023) -
Adoption of opioid-prescribing guidelines in primary care: a realist synthesis of contextual factors
por: Jacobson, Nora, et al.
Publicado: (2021)